Description
CJC-1295 (no DAC) + Ipamorelin blend (10 mg) is supplied as a lyophilized powder in a Type I borosilicate glass vial sealed under vacuum. This blend combines CJC-1295 (no DAC) — a synthetic GHRH-analog peptide — with Ipamorelin, a pentapeptide GHSR agonist. Studied in-vitro for somatotroph-axis research.
Multi-component research blend. CJC-1295 (no DAC): 30 aa · Ipamorelin: 5 aa.
Every production lot is synthesized in a validated cGMP-grade research facility and independently assayed by accredited third-party analytical laboratories using reverse-phase HPLC and mass spectrometry. Each vial is verified to ≥99.0% purity and shipped with a certificate of analysis tied to the unique vial code printed on the label.
Research Use Only. This product is sold strictly as a research chemical for in-vitro laboratory study by qualified researchers and institutional laboratories. Not for human consumption, therapeutic use, or administration of any kind. Not a drug, food, cosmetic, or dietary supplement.




